Literature DB >> 15722103

A-type nuclear lamins, progerias and other degenerative disorders.

Erica D Smith1, Brian A Kudlow, Richard L Frock, Brian K Kennedy.   

Abstract

Nuclear lamins were identified as core nuclear matrix constituents over 20 years ago. They have been ascribed structural roles such as maintaining nuclear integrity and assisting in nuclear envelope formation after mitosis, and have also been linked to nuclear activities including DNA replication and transcription. Recently, A-type lamin mutations have been linked to a variety of rare human diseases including muscular dystrophy, lipodystrophy, cardiomyopathy, neuropathy and progeroid syndromes (collectively termed laminopathies). Most diseases arise from dominant, missense mutations, leading to speculation as to how different mutations in the same gene can give rise to such a diverse set of diseases, some of which share little phenotypic overlap. Understanding the cellular dysfunctions that lead to laminopathies will almost certainly provide insight into specific roles of A-type lamins in nuclear organization. Here, we compare and contrast the LMNA mutations leading to laminopathies with emphasis on progerias, and discuss possible functional roles for A-type lamins in the maintenance of healthy tissues.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15722103     DOI: 10.1016/j.mad.2004.10.006

Source DB:  PubMed          Journal:  Mech Ageing Dev        ISSN: 0047-6374            Impact factor:   5.432


  22 in total

1.  Collagen expression in fibroblasts with a novel LMNA mutation.

Authors:  Desiree Nguyen; Dru F Leistritz; Lesley Turner; David MacGregor; Kamal Ohson; Paul Dancey; George M Martin; Junko Oshima
Journal:  Biochem Biophys Res Commun       Date:  2006-11-27       Impact factor: 3.575

Review 2.  Laminopathies: multiple disorders arising from defects in nuclear architecture.

Authors:  Veena K Parnaik; Kaliyaperumal Manju
Journal:  J Biosci       Date:  2006-09       Impact factor: 1.826

Review 3.  Adult stem cell maintenance and tissue regeneration in the ageing context: the role for A-type lamins as intrinsic modulators of ageing in adult stem cells and their niches.

Authors:  Vanja Pekovic; Christopher J Hutchison
Journal:  J Anat       Date:  2008-07       Impact factor: 2.610

Review 4.  Hutchinson-Gilford Progeria Syndrome: A Premature Aging Disease.

Authors:  Muhammad Saad Ahmed; Sana Ikram; Nousheen Bibi; Asif Mir
Journal:  Mol Neurobiol       Date:  2017-06-28       Impact factor: 5.590

5.  The defective nuclear lamina in Hutchinson-gilford progeria syndrome disrupts the nucleocytoplasmic Ran gradient and inhibits nuclear localization of Ubc9.

Authors:  Joshua B Kelley; Sutirtha Datta; Chelsi J Snow; Mandovi Chatterjee; Li Ni; Adam Spencer; Chun-Song Yang; Caelin Cubeñas-Potts; Michael J Matunis; Bryce M Paschal
Journal:  Mol Cell Biol       Date:  2011-06-13       Impact factor: 4.272

6.  Stabilization of the retinoblastoma protein by A-type nuclear lamins is required for INK4A-mediated cell cycle arrest.

Authors:  Ryan T Nitta; Samantha A Jameson; Brian A Kudlow; Lindus A Conlan; Brian K Kennedy
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

7.  Topology of yeast Ndc1p: predictions for the human NDC1/NET3 homologue.

Authors:  Corine K Lau; Valerie A Delmar; Douglass J Forbes
Journal:  Anat Rec A Discov Mol Cell Evol Biol       Date:  2006-07

Review 8.  DNA-damage accumulation and replicative arrest in Hutchinson-Gilford progeria syndrome.

Authors:  Phillip R Musich; Yue Zou
Journal:  Biochem Soc Trans       Date:  2011-12       Impact factor: 5.407

9.  Lamin A/C and emerin are critical for skeletal muscle satellite cell differentiation.

Authors:  Richard L Frock; Brian A Kudlow; Angela M Evans; Samantha A Jameson; Stephen D Hauschka; Brian K Kennedy
Journal:  Genes Dev       Date:  2006-02-15       Impact factor: 11.361

Review 10.  Genomic instability and DNA damage responses in progeria arising from defective maturation of prelamin A.

Authors:  Phillip R Musich; Yue Zou
Journal:  Aging (Albany NY)       Date:  2009-01       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.